These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 32533288

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. EZH2 suppresses insulinoma development by epigenetically reducing KIF4A expression via H3K27me3 modification.
    Zhang S, Liu J, Li F, Yang M, Wang J.
    Gene; 2022 May 15; 822():146317. PubMed ID: 35182680
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. ciRS-7 is a prognostic biomarker and potential gene therapy target for renal cell carcinoma.
    Mao W, Wang K, Xu B, Zhang H, Sun S, Hu Q, Zhang L, Liu C, Chen S, Wu J, Chen M, Li W, Peng B.
    Mol Cancer; 2021 Nov 05; 20(1):142. PubMed ID: 34740354
    [Abstract] [Full Text] [Related]

  • 10. microRNA‑572 functions as an oncogene and a potential biomarker for renal cell carcinoma prognosis.
    Pan X, Li Z, Zhao L, Quan J, Zhou L, Xu J, Xu W, Guan X, Li H, Yang S, Gui Y, Lai Y.
    Oncol Rep; 2018 Nov 05; 40(5):3092-3101. PubMed ID: 30132566
    [Abstract] [Full Text] [Related]

  • 11. MicroRNA-200b is downregulated and suppresses metastasis by targeting LAMA4 in renal cell carcinoma.
    Li Y, Guan B, Liu J, Zhang Z, He S, Zhan Y, Su B, Han H, Zhang X, Wang B, Li X, Zhou L, Zhao W.
    EBioMedicine; 2019 Jun 05; 44():439-451. PubMed ID: 31130475
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. miR-129-3p, as a diagnostic and prognostic biomarker for renal cell carcinoma, attenuates cell migration and invasion via downregulating multiple metastasis-related genes.
    Chen X, Ruan A, Wang X, Han W, Wang R, Lou N, Ruan H, Qiu B, Yang H, Zhang X.
    J Cancer Res Clin Oncol; 2014 Aug 05; 140(8):1295-304. PubMed ID: 24802708
    [Abstract] [Full Text] [Related]

  • 14. Oncogene miR-154-5p regulates cellular function and acts as a molecular marker with poor prognosis in renal cell carcinoma.
    Lin C, Li Z, Chen P, Quan J, Pan X, Zhao L, Zhou L, Lai Y, He T, Xu W, Xu J, Guan X, Li H, Yang S, Hu Y, Lai Y.
    Life Sci; 2018 Sep 15; 209():481-489. PubMed ID: 30138594
    [Abstract] [Full Text] [Related]

  • 15. Circular RNA circ-EGLN3 promotes renal cell carcinoma proliferation and aggressiveness via miR-1299-mediated IRF7 activation.
    Lin L, Cai J.
    J Cell Biochem; 2020 Nov 15; 121(11):4377-4385. PubMed ID: 31904147
    [Abstract] [Full Text] [Related]

  • 16. CircTLK1 promotes the proliferation and metastasis of renal cell carcinoma by sponging miR-136-5p.
    Li J, Huang C, Zou Y, Ye J, Yu J, Gui Y.
    Mol Cancer; 2020 Jun 05; 19(1):103. PubMed ID: 32503552
    [Abstract] [Full Text] [Related]

  • 17. miR-566 functions as an oncogene and a potential biomarker for prognosis in renal cell carcinoma.
    Pan X, Quan J, Li Z, Zhao L, Zhou L, Jinling X, Weijie X, Guan X, Li H, Yang S, Gui Y, Lai Y.
    Biomed Pharmacother; 2018 Jun 05; 102():718-727. PubMed ID: 29604591
    [Abstract] [Full Text] [Related]

  • 18. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
    Rabjerg M.
    Dan Med J; 2017 Oct 05; 64(10):. PubMed ID: 28975890
    [Abstract] [Full Text] [Related]

  • 19. NDRG2 is involved in the oncogenic properties of renal cell carcinoma and its loss is a novel independent poor prognostic factor after nephrectomy.
    Liang ZL, Kang K, Yoon S, Huang SM, Lim JS, Kim JM, Lim JS, Lee HJ.
    Ann Surg Oncol; 2012 Aug 05; 19(8):2763-72. PubMed ID: 22246425
    [Abstract] [Full Text] [Related]

  • 20. MicroRNA‑21 contributes to renal cell carcinoma cell invasiveness and angiogenesis via the PDCD4/c‑Jun (AP‑1) signalling pathway.
    Fan B, Jin Y, Zhang H, Zhao R, Sun M, Sun M, Yuan X, Wang W, Wang X, Chen Z, Liu W, Yu N, Wang Q, Liu T, Li X.
    Int J Oncol; 2020 Jan 05; 56(1):178-192. PubMed ID: 31789394
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.